Fifth Third Bancorp’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$171K Buy
8,750
+8,241
+1,619% +$202K ﹤0.01% 2626
2025
Q4
$13.6K Buy
509
+58
+13% +$1.49K ﹤0.01% 2034
2025
Q3
$12K Sell
451
-29
-6% -$749 ﹤0.01% 2083
2025
Q2
$11K Buy
480
+108
+29% +$2.68K ﹤0.01% 1978
2025
Q1
$10.8K Sell
372
-51
-12% -$1.63K ﹤0.01% 1976
2024
Q4
$15.7K Sell
423
-210
-33% -$9.6K ﹤0.01% 1839
2024
Q3
$30.7K Buy
633
+23
+4% +$1.01K ﹤0.01% 1623
2024
Q2
$24.4K Buy
610
+2
+0.3% +$83 ﹤0.01% 1655
2024
Q1
$26.7K Buy
608
+9
+2% +$465 ﹤0.01% 1578
2023
Q4
$37K Sell
599
-15
-2% -$788 ﹤0.01% 1510
2023
Q3
$28.2K Hold
614
﹤0.01% 1604
2023
Q2
$35.3K Sell
614
-20
-3% -$887 ﹤0.01% 1505
2023
Q1
$23.8K Buy
634
+59
+10% +$1.93K ﹤0.01% 1755
2022
Q4
$16.1K Sell
575
-107
-16% -$3.11K ﹤0.01% 1785
2022
Q3
$19K Sell
682
-77
-10% -$2.51K ﹤0.01% 1695
2022
Q2
$26K Buy
759
+222
+41% +$7.92K ﹤0.01% 1620
2022
Q1
$19K Buy
537
+89
+20% +$2.52K ﹤0.01% 1822
2021
Q4
$10K Buy
448
+373
+497% +$7.63K ﹤0.01% 2078
2021
Q3
$1K Buy
+75
New +$1.47K ﹤0.01% 2544

Other funds holding AMPH

Fifth Third Bancorp's AMPH Position: Q1 2026 in Review

Fifth Third Bancorp increased its Amphastar Pharmaceuticals (AMPH) stake by 1,619% in Q1 2026, buying an estimated $202K and bringing the position to 8,750 shares worth $171K. The position accounts for ﹤0.01% of the portfolio, ranked #2626.

Fifth Third Bancorp first reported a position in AMPH in Q3 2021 and has held it in 19 quarters since. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

  • Fifth Third Bancorp held 8,750 shares of Amphastar Pharmaceuticals worth $171K as of Q1 2026.
  • Fifth Third Bancorp bought 8,241 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $202K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #2626 holding.
  • Fifth Third Bancorp first reported a position in Amphastar Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.